What Bharat Parenter. promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q4 FY26

what the last two calls moved 18 tracked 2 delivered 5 missed 11 open

Innoxel FY26 Revenue delivered said Q4 FY25 Promised: around INR70 crores Q4 FY26: Achieved. Full year FY26 revenue was INR 72.4 crores, exceeding the original and revised guidance.
Innoxel Operational Break-even missed said Q4 FY25 Promised: operationally break even in this FY '26 at Innoxel Q4 FY26: Missed. Full year FY26 EBITDA was a loss of INR 6.9 crores, despite turning positive in Q4.
Varenyam Bio Lifesciences Operational Timeline delayed said Q4 FY25 Promised: operational by 2027 Q4 FY26: Significantly delayed. Commissioning now targeted for Sep 2027, with first commercial supply in Q4 FY29.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 18 tracked commitments for Bharat Parenter. — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens